Ampio Pharmaceuticals Pipeline
Ampio’s two lead product candidates are advancing through late-stage clinical trials in the United States. Ampio has initiated the second of two pivotal trials for Ampion, a biologic intra-articular injection being studied for the treatment of pain due osteoarthritis of the knee. A late-stage US-based clinical trial is also underway for Optina, an oral agent being studied for the treatment of diabetic macular edema. Additional clinical trials are planned for these and other product candidates.